
Apollo Sindoori Analyst Review 2027: Revenue Up 29% but Thin Margins Keep Profit Small
Updated: 20 Nov 2026 • 9:44 am
Posted by:

Apollo Sindoori Hotels Stock Snapshot (19 Nov 2026)
- Current Market Price (CMP): ₹1,165.20
- 52-Week High / Low: ₹1,440.00 / ₹950.00
- Market Capitalisation: ₹303 crore
- P/E Ratio vs Industry P/E: 38.4 vs 39.6
- Latest Quarter (Q2 FY27) Revenue: ₹197.34 crore
- Latest Quarter (Q2 FY27) Net Profit: ₹2.67 crore
Quick Answer: The Apollo Sindoori analyst review 2027 finds no brokerage coverage as of November 2026. Q2 FY27 revenue rose 29.5% to ₹197.34 crore, but net profit fell 13.6% to ₹2.67 crore as EBITDA margin stayed near 5.6%. The stock closed at ₹1,165.20 on 19 November 2026, about 38 times trailing earnings, so any Apollo Sindoori share price target 2027 view depends on whether strong sales growth can finally turn into higher profit.
The Apollo Sindoori analyst review 2027 covers Apollo Sindoori Hotels, a Chennai-based company linked to the Apollo Hospitals founding family that provides food services, catering and related hospitality support to hospitals, corporate campuses and institutions. Readers searching for an Apollo Sindoori share price target 2027 will not find any named brokerage figure, so this review relies on results and valuation.
Apollo Sindoori Hotels closed at ₹1,165.20 on 19 November 2026, about 19% below its 52-week high of ₹1,440 and about 23% above its low of ₹950. This Apollo Sindoori analyst review 2027 explains why revenue growth has not lifted profit and what shapes the Apollo Sindoori stock outlook 2027.
Click Here – Get Free Investment Predictions
What Analysts Say in the Apollo Sindoori Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| No verified coverage | Not available | Not available | As of November 2026 |
No brokerage covers Apollo Sindoori. With a market value of about ₹303 crore, no institutional shareholders and thin trading, the stock sits outside the coverage lists of research houses.
Book value of about ₹616 a share and the revenue trend are the main reference points. This Apollo Sindoori analyst review 2027 uses both to judge how the market values the company.
Q2 FY27 Results in the Apollo Sindoori Analyst Review 2027
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | ₹197.34 crore | ₹152.42 crore | Up 29.5% |
| EBITDA | ₹11.01 crore | ₹9.34 crore | Up 17.9% |
| EBITDA margin | About 5.6% | About 6.1% | Down about 50 bps |
| Net profit | ₹2.67 crore | ₹3.09 crore | Down 13.6% |
| H1 FY27 net profit | ₹4.43 crore | Not compared | Small |
Revenue reached a quarterly record and has risen in three of the last four quarters, from ₹152.42 crore a year ago to ₹197.34 crore. EBITDA grew more slowly, so margin slipped by about half a percentage point.
Net profit fell because depreciation, interest and tax absorbed most of the operating gain. In this Apollo Sindoori analyst review 2027, a net margin of only about 1.4% is the main weakness, since small cost changes can wipe out profit.
How Apollo Sindoori Makes Money
Apollo Sindoori earns fees for running food and support services on behalf of its clients.
- Hospital food services: patient meals, staff canteens and cafeterias in hospitals.
- Corporate catering: food courts and canteens for offices and industrial campuses.
- Institutional services: catering for schools, colleges and other institutions.
- Support services: housekeeping and allied facility services for clients.
FY26 revenue rose to ₹641.6 crore from ₹552.1 crore, and net profit rose to ₹10.5 crore from ₹7.7 crore, though it remained below ₹11.1 crore in FY24. Those numbers frame this Apollo Sindoori analyst review 2027, because profit has barely grown while revenue has risen by about a fifth over two years.
Contract catering is a people-heavy business with thin margins. Contracts are often renewed through competitive bids, and food and wage costs can rise faster than the company can reprice. Large clients such as hospital chains have strong bargaining power, which caps how much margin a caterer can earn.
The connection with the Apollo Hospitals founding family can help the company win hospital clients, but any reliance on group businesses would concentrate revenue with related parties. Operating cash flow improved to about ₹40 crore in FY26 from ₹21 crore in FY25. Large consumer-facing companies in the Sensex usually earn far higher margins than contract service providers like Apollo Sindoori.
Scale is the main lever for better profitability. Spreading central kitchen, procurement and management costs over a larger revenue base can lift margins, and the 29.5% revenue growth in Q2 gives the company that opportunity if costs stay under control.
Working capital also matters in this business. Large institutional clients often pay on credit terms, so faster growth can tie up cash in receivables. The improvement in operating cash flow in FY26 suggests collections kept pace with revenue, which is encouraging as the company expands.
Growth Triggers in the Apollo Sindoori Analyst Review 2027
- Revenue growth: up 29.5% to a record ₹197.34 crore.
- Healthcare demand: more hospital beds mean more food service contracts.
- Corporate offices: return-to-office trends support canteen demand.
- Cash flow: about ₹40 crore of operating cash in FY26.
- Book value: about ₹616 a share, relevant to any Apollo Sindoori share price target 2027 view.
Key Risks in the Apollo Sindoori Analyst Review 2027
- Thin margins: net margin of about 1.4% in Q2.
- Cost inflation: food and wage costs can rise quickly.
- Contract renewals: competitive bidding for large clients.
- Client concentration: large hospital and corporate clients carry bargaining power.
- Low liquidity: thin trading in a small stock, a core point in the Apollo Sindoori analyst review 2027.
Compare Apollo Sindoori With Other Hospitality Stocks on the Univest Screener
Apollo Sindoori Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (19 Nov 2026) | ₹1,165.20 |
| 52-Week High / Low | ₹1,440.00 / ₹950.00 |
| Market Capitalisation | About ₹303 crore |
| P/E (TTM) | About 38.4 |
| Industry P/E | About 39.6 |
| Price to Book | About 1.89 |
| Book Value per Share | ₹615.62 |
| Debt to Equity | 0.60 |
| FY26 Revenue / Net Profit | ₹641.6 crore / ₹10.5 crore |
The P/E of about 38 is in line with the industry level, but return on equity is only about 5%. In this Apollo Sindoori analyst review 2027, the multiple looks high for a business earning such low returns on its capital.
Shareholding Trend
| Holder | Sep 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 64.68% | 64.68% | No change |
| Foreign Investors (FII) | 0.00% | 0.00% | No change |
| Domestic Institutions (DII) | 0.00% | 0.00% | No change |
| Public | 35.32% | 35.32% | No change |
Prathap C Reddy holds 14.12% and Sucharitha P Reddy 13.24%, and the promoter stake did not change. There are no institutional holders, which the Apollo Sindoori analyst review 2027 sees as a sign of limited professional interest.
What to Watch After the Apollo Sindoori Analyst Review 2027
- Margins: whether EBITDA margin moves above 6%.
- Contract wins: new hospital and corporate clients.
- Cost control: food and wage inflation.
- Profit growth: quarterly profit above ₹3 crore.
- Coverage: any research that sets an Apollo Sindoori share price target 2027.
Final Word on the Apollo Sindoori Analyst Review 2027
The Apollo Sindoori analyst review 2027 shows strong revenue growth and better cash flow, held back by thin margins, flat profit and low returns on equity. The stock trades at a full earnings multiple for a contract services business.
The Apollo Sindoori stock outlook 2027 depends on margins and contract wins. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Apollo Sindoori analyst review 2027 show?
It shows strong sales but weak profit. Q2 FY27 revenue rose 29.5% to ₹197.34 crore, while net profit fell 13.6% to ₹2.67 crore. EBITDA margin slipped to about 5.6%.
Is there an Apollo Sindoori share price target 2027 from brokerages?
No named brokerage target exists as of November 2026. The stock closed at ₹1,165.20 on 19 November 2026, about 19% below its 52-week high of ₹1,440. Results and book value are the main reference points.
What does Apollo Sindoori Hotels do?
Apollo Sindoori provides food services, catering and support services to hospitals, corporate campuses and institutions. It is based in Chennai and linked to the Apollo Hospitals founding family. Hospital food services are a key part of its business.
Why is Apollo Sindoori's profit so low?
Contract catering is people-heavy, with high food and wage costs and limited pricing power. Net margin was only about 1.4% in Q2 FY27. FY26 profit was ₹10.5 crore on revenue of ₹641.6 crore.
Is Apollo Sindoori stock expensive based on the Apollo Sindoori analyst review 2027?
The stock trades at about 38 times earnings, close to the industry P/E of about 39.6. Return on equity is only about 5%, and price to book is about 1.89. The multiple looks high for such low returns.
What risks does the Apollo Sindoori analyst review 2027 highlight?
The main risks are thin margins, food and wage inflation and competitive contract renewals. Large clients have strong bargaining power. The stock is thinly traded.
What should investors track after the Apollo Sindoori analyst review 2027?
Track whether EBITDA margin rises above 6% and quarterly profit moves above ₹3 crore. Watch new hospital and corporate contract wins. Cost control on food and wages also matters.
Recent Articles

Aries Agro Analyst Review 2027: Record Kharif Quarter With Profit Up 27% Near a 52-Week High
20 November 2026

Archies Analyst Review 2027: Revenue Falls 33% and Losses Widen as the Stock Hits Near Lows
20 November 2026

Archidply Industries Analyst Review 2027: Profit More Than Doubles at Under 10 Times Earnings
20 November 2026

Aptech Analyst Review 2027: Profit Up 42% as Margins Recover, Stock Still Far Below Its High
20 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Aries Agro Analyst Review 2027: Record Kharif Quarter With Profit Up 27% Near a 52-Week High
Archies Analyst Review 2027: Revenue Falls 33% and Losses Widen as the Stock Hits Near Lows
Archidply Industries Analyst Review 2027: Profit More Than Doubles at Under 10 Times Earnings
Aptech Analyst Review 2027: Profit Up 42% as Margins Recover, Stock Still Far Below Its High
Apollo Sindoori Analyst Review 2027: Revenue Up 29% but Thin Margins Keep Profit Small
Popular this week
Arman Financial Analyst Review 2027: Record ₹51 Crore Profit as Credit Costs Ease and AUM Tops ₹3,000 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





